High-risk Characteristics of Pathological Stage I Lung Adenocarcinoma after Resection: Patients for Whom Adjuvant Chemotherapy Should Be Performed

Lei-Lei Wu,Wen-Mei Jiang,Jia-Yi Qian,Jia-Yuan Tian,Zhi-Xin Li,Kun Li,Guo-Wei Ma,Dong Xie,Chang Chen
DOI: https://doi.org/10.1016/j.heliyon.2023.e23207
IF: 3.776
2023-01-01
Heliyon
Abstract:Background: The objective of the present study was to identify patients with pathologic stage I lung adenocarcinoma (LUAD) who are at high risk of recurrence and assess the efficacy of adjuvant chemotherapy (ACT) in these individuals.Methods: A retrospective study was conducted on 1504 patients with pathologic stage I LUAD who underwent surgical resection at Shanghai Pulmonary Hospital and Sun Yat-sen University Cancer Center. Cox proportional hazard regression analyses were performed to identify indicators associated with a high risk of recurrence, while the Kaplan-Meier method and Log-rank test were employed to compare recurrence-free survival (RFS) and overall survival (OS) between patients with ACT and those without it.Results: Four independent indicators, including age (>= 62 years), visceral pleural invasion (VPI), predominant pattern (micropapillary/solid), and lymphovascular invasion (LVI), were identified to be significantly related with RFS. Subsequently, patients were classified into high-risk and lowrisk groups by LVI, VPI, and predominant pattern. The administration of ACT significantly increased both RFS (P < 0.001) and OS (P = 0.03) in the high-risk group (n = 250). Conversely, no significant difference was observed in either RFS (P = 0.45) or OS (P = 0.063) between ACT and non-ACT patients in the low-risk group (n = 1254).Conclusions: Postoperative patients with stage I LUAD with factors such as LVI, VPI, and micropapillary/solid predominant pattern may benefit from ACT.
What problem does this paper attempt to address?